Neumora Therapeutics, Inc. (NMRA)
2025-06-30 | ||||
|---|---|---|---|---|
| Unrealized loss on marketable securities | -12 | |||
| Provision for income taxes | 25 | |||
| Loss from operations | -54,040 | |||
| Other expense, net | -480 | |||
| Interest income, net | 1,814 | |||
| Total other income | 1,334 | |||
| Net loss before income taxes | -52,706 | |||
| Net loss | -52,731 | |||
| Comprehensive loss | -52,743 | |||
| Earnings per share, basic, total | -0.33 | |||
| Earnings per share, diluted, total | -0.33 | |||
| Weighted average number of shares outstanding, basic, total | 161,691,000 | |||
| Weighted average number of shares outstanding, diluted, total | 161,691,000 | |||